GlaxoSmithKline has begun distributing a medicine tagged with radio frequency identification (RFID) technology as part of a pilot project to help protect patient safety. The tags will be placed on all bottles of Trizivir, an HIV medicine, distributed in the U.S. When scanned at close range, the tags will help verify that the medicine bottle contains authentic Trizivir. This drug was selected for the project because it has been listed by the National Association of Boards of Pharmacy as one of 32...